Nurse Practitioner, Family · New York, NY
NPI
1568836161
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
240 E 38th St Fl 19
New York, NY, 10016
Phone (212) 731-5855
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$7.3M
1,418 prescriptions
Company payments, 2025
$97.28
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Vathveal Mathews prescribed most often to Medicare patients was Acyclovir, with 248 prescriptions and refills. In total Vathveal Mathews wrote 1,418 Medicare prescriptions that cost $7.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-06.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Acyclovir Generic | 248 | 360 | 47 | $3,358 |
| Eliquis Apixaban | 80 | 98 | 17 | $56K |
| Lenalidomide Generic | 75 | 75 | 12 | $1.0M |
| Hydroxyurea Generic | 63 | 127 | 19 | $1,365 |
| Revlimid Lenalidomide | 62 | 62 | 14 | $1.2M |
| Xarelto Rivaroxaban | 61 | 87 | 15 | $46K |
| Pomalyst Pomalidomide | 54 | 54 | Under 11 | $1.2M |
| Allopurinol Generic | 34 | 48 | Under 11 | $211 |
| Levofloxacin Generic | 30 | 30 | 12 | $170 |
| Venclexta Venetoclax | 28 | 28 | Under 11 | $394K |
| Brukinsa Zanubrutinib | 27 | 27 | Under 11 | $370K |
| Dexamethasone Generic | 27 | 40 | Under 11 | $522 |
| Gabapentin Generic | 26 | 43 | Under 11 | $222 |
| Promacta Eltrombopag Olamine | 25 | 25 | Under 11 | $283K |
| Cyclosporine Generic | 25 | 29 | Under 11 | $7,695 |
Brand drugs: - claims; generic drugs: 866 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vathveal Mathews $97.28 ($97.28 in general payments such as food, travel and fees) from 2 companies. The largest payer was Janssen Biotech, Inc. with $73.07.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.